JARVIK HEART Announces Full FDA Approval of the Jarvik 2000 Destination ... Sacramento Bee Device to Provide Long-term, Permanent Support for Heart Failure Patients Who are Not Eligible for Transplant. Approval was also granted for Continuing Access Protocol (CAP) Patients Following Completion of Enrollment in the Bridge to Transplant Trial. FDA approves clinical trial for cardiac assist device for patients ineligible ... |
